✦ LIBER ✦

The effect of bicalutamide on prostate histology

✍ Scribed by Lars Magne Eri; Aud Svindland; Kjell J. Tveter

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 275 KB
Volume: 46
Category: Article
ISSN: 0270-4137
DOI: 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE EFFECT OF FOOD ON THE PHARMACOKINETI

THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF THE BICALUTAMIDE (‘CASODEX’) ENANTIOMERS

✍ I. D. COCKSHOTT; S. D. OLIVER; J. J. YOUNG; K. J. COOPER; D. C. JONES 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Casodex' (bicalutamide) is an orally active, non-steroidal, pure antiandrogen; it is a racemate with antiandrogenic activity residing predominantly in the (R)-enantiomer. Healthy male volunteers (n=15) were administered single oral doses of bicalutamide (50 mg) after food and after fasting as part o

Bicalutamide dosages used in the treatme

Bicalutamide dosages used in the treatment of prostate cancer

✍ Kolvenbag, Geert J.C.M.; Nash, Anthony 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used

Effects of pituitary hormones on the pro

Effects of pituitary hormones on the prostate

✍ Reiter, Eric; Hennuy, Benoit; Bruyninx, Marc; Cornet, Anne; Klug, Marc; McNamara 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Background: Although essential, androgens alone are not sufficient to induce normal growth and functionality of the prostate. nonandrogenic hormones must also be involved in the proliferation of the prostate cancer cells which do not respond to antiandrogenic therapy and which thus become androg

Bicalutamide (Casodex®) in the treatment

Bicalutamide (Casodex®) in the treatment of prostate cancer: History of clinical development

✍ Kolvenbag, Geert J.C.M.; Blackledge, George R.P.; Gotting-Smith, Karen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria

The effect of transurethral prostatic re

The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis

✍ Deborah A. Kuban; Anas M. El-Mahdi; Paul F. Schellhammer; Therese J. Babb 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 1 views

Race and the histologic grade of prostat

Race and the histologic grade of prostate cancer

✍ Freeman, Vincent L.; Leszczak, Jaroslaw; Cooper, Richard S. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

We collected data on the histologic grade, stage, and age at diagnosis of 4,114 cases of prostate cancer (1,380 blacks, and 2,734 whites) in the Chicago area. The relationship between histologic grade (high = poorly or undifferentiated vs. low = well or moderatly differentiated) and race (black vs.